Registry study for acute myocarditis with heart imaging
Part of Heart & circulation clinical trials.
This study collects information from people with newly diagnosed acute myocarditis using heart scans and, in some cases, a biopsy. It aims to understand what predicts recovery and which test results matter most for outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute myocarditis using a heart MRI or a heart biopsy
- Your diagnosis must meet specific accepted criteria used by cardiology specialists
- You are covered by the French public health system (Sécurité sociale)
- You do not have severe problems with your heart valves
- You do not have a complex congenital (from-birth) heart condition
- You have not had a previous heart transplant and you do not have significant known coronary artery disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses heart scans (MRI or nuclear imaging) to better understand inflammatory heart conditions. If you have a suspected inflammatory heart disease and are already scheduled for one of these scans, you may be able to join.
This study is collecting information from people who have had chest pain but no blockages in their heart arteries, to better understand a condition called myocarditis. Participating means allowing researchers to review your health records and possibly answer questions.
This study uses a special heart MRI to look closely at inflammation in the heart muscle. It helps doctors better understand and treat myocarditis and inflammatory cardiomyopathy.
This trial uses special heart imaging tests (MRI or CT scans) to look at the hearts of children with myocarditis, a condition where the heart muscle is inflamed. The goal is to better understand the inflammation and help guide treatment.
This study looks at whether a simple blood test for troponin (a protein released when heart muscle is damaged) can help doctors predict how patients with acute myocarditis (heart muscle inflammation) will do over time. It may help guide follow-up care for people recovering from this condition.
This study looks at certain markers in your blood to better understand the risk level of myocarditis (inflammation of the heart muscle). It may help doctors know how to best monitor and treat your condition.
Hear when a new Myocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.